Category: Research & Development
Research & Development market research reports by GlobalData
-
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 Summary Schizophrenia is a chronic and debilitating mental illness, characterized by delusions, hallucinations, disorganized speech, trouble with thinking, and a lack of motivation. It is among the most disabling and economically catastroph ... Read More
-
Clinical Trials Sector Scorecard, Q2 2022 Update - Thematic Research
Clinical Trials Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Virtual Care Landscape Saw Activity in Q2 2022: In Q2 2022, there was increased activity in the virtual care space. Compared to Q1 2022, Novo Nordisk initiated more trials with virtual components and also posted more jo ... Read More
-
Artificial Intelligence (AI) in Drug Discovery - Thematic Research
Artificial Intelligence (AI) in Drug Discovery - Thematic Research Summary In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more interest in t ... Read More
-
Israel Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Israel Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Israel Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Comp ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Major Depressive Disorder therapeutics. Synopsis In 2022, there will be more than 18 mil ... Read More
-
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rosacea therapeutics. Synopsis In 2022, there will be more than 47 million diagnosed prevalent cases of ro ... Read More
-
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Neuroendocrine Tumors Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Neuroendocrine tumors therapeutics. Synopsis In 2022, diagnosed prevalence of Neuroendocrine ... Read More
-
Alport Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Alport Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Alport Syndrome therapeutics. Synopsis In 2022, diagnosed prevalence of Alport syndrome will reach ... Read More
-
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Bacterial Vaginosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, St ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial ... Read More
-
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Pancreatitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor ... Read More
-
Big Data in Pharmaceuticals - Thematic Research
Big Data in Pharmaceuticals - Thematic Research Summary This report provides an overview of the big data analytics in the pharma industry. Big data is generated in vast quantities across healthcare The healthcare and pharmaceutical industries generate data in abundance from a multitude of sources in ... Read More
-
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022
Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer - March 2022 Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Com ... Read More
-
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
Osteosarcoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027 Summary This reports provides a data-driven overview of the current and future competitive landscape in osteosarcoma therapeutics. In osteosarcoma Cells expressing ganglioside GD2 ... Read More
-
Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape
Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape Summary GlobalData, the industry analysis specialist, has released its latest report: “Vietnam Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and C ... Read More
-
Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2021
Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2021 Summary GlobalData's “Pharmaceutical and Healthcare Sector Mergers, Acquisitions and Investment Trend Annual Review - 2021” report is an essential source of data and trend analysis on partnerships, l ... Read More
-
Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030
Atopic Dermatitis - Epidemiology Analysis and Forecast, 2020-2030 Summary Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Although the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Co ... Read More
-
Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape
Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape Summary GlobalData, the industry analysis specialist, has released its latest report “Saudi Arabia - Healthcare (Pharmaceuticals and Medical Devices), Regulatory and Reimbursement Landscape”. The ... Read More
-
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030
Bipolar Disorder - Global Drug Forecast and Market Analysis to 2030 Summary Bipolar disorder, known originally as manic-depressive illness, is a mental disorder characterized by periods of mania and depression. Manic episodes are the distinguishing feature of this condition and consist of an abnorma ... Read More
-
Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research
Global Mergers and Acquisitions (M&A) Deals in 2021 - Top Themes in the Pharmaceuticals Sector - Thematic Research Summary This report analyzes the disruptive themes that have driven M&A activity in 2021 in the Pharma Sector M&A deal value in global Pharma sector grew by 15%, from $191 billion in 20 ... Read More
Research Assistance
